Resveratrol (Expanded) for Blood Sugar Regulation

Research suggests that resveratrol supplementation may support blood sugar regulation, with a notably consistent body of evidence pointing in a favorable direction across multiple study types. Meta-analyses and randomized controlled trials have reported reductions in fasting blood glucose, insulin levels, HbA1c, and markers of insulin resistance such as HOMA-IR in individuals with type 2 diabetes, while mechanistic reviews propose that these effects may involve SIRT1 activation, GLUT4 upregulation, improved vascular function, and enhanced GLP-1 secretion. Animal and cell-based research further supports these pathways, and a 2006 mouse study demonstrating protection against diet-induced insulin resistance via SIRT1/PGC-1alpha signaling has been influential in shaping the mechanistic understanding. That said, many of the human trials are relatively short in duration and modest in scale, and while the overall direction of evidence is supportive, readers should be aware that effect sizes, optimal populations, and long-term outcomes remain areas where further research is warranted.